CHE
Chemed Corporation · Healthcare · Medical Care Facilities
Last
$423.30
−$3.11 (−0.73%) 4:00 PM ET
Prev close $426.41
Open $426.33
Day high $432.27
Day low $418.59
Volume 176,423
Avg vol 250,112
Mkt cap
$5.66B
P/E ratio
23.11
FY Revenue
$2.54B
EPS
18.32
Gross Margin
32.38%
Sector
Healthcare
AI report sections
CHE
Chemed Corporation
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
−8% (Below avg)
Vol/Avg: 0.92×
RSI
51.39 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
+0.37 (Strong)
MACD: 1.05 Signal: 0.68
Short-Term
-1.42 (Weak)
MACD: 8.37 Signal: 9.79
Long-Term
+0.39 (Strong)
MACD: 12.82 Signal: 12.43
Intraday trend score 37.00

Latest news

CHE 12 articles Positive: 4 Neutral: 3 Negative: 2
Neutral GlobeNewswire Inc. • Na
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

Chemed Corporation held its 2026 annual stockholders meeting where nine directors were elected and PricewaterhouseCoopers LLP was ratified as independent accountants. However, the non-binding proposal on executive compensation was not approved. The board declared a quarterly cash dividend of $0.60 per share, marking the 220th consecutive quarterly dividend in the company's 55-year history as a public company.

CHE stockholders meeting board of directors executive compensation dividend independent accountants hospice care plumbing services
Sentiment note

Mixed signals: positive aspects include consistent dividend payments (220th consecutive quarterly dividend) and successful director election, but negative aspect is the rejection of the executive compensation proposal, indicating shareholder dissatisfaction with compensation practices.

Positive GlobeNewswire Inc. • Not Specified
Water Management Takes Centre Stage at Data Centre LIVE

Data Centre LIVE: The London Summit (20-21 May at Exhibition White City) will feature a dedicated panel on water management strategies for data centres. The event will explore innovative cooling technologies and site design approaches to reduce water consumption while maintaining operational performance. Industry experts including representatives from Chem-Aqua and Evapco Europe will share practical solutions for optimizing water use and aligning with sustainability commitments.

CHE water management data centre sustainability cooling technologies water efficiency ESG commitments liquid cooling WUE metrics
Sentiment note

Company is featured as an industry expert speaker at a major sustainability-focused event, positioning it as a thought leader in water efficiency solutions for data centres.

Positive Benzinga • Na
Roto-Rooter Completes Acquisitions for Two Significant Territories

Roto-Rooter Services Company, a subsidiary of Chemed Corporation, has completed acquisitions of franchise territories in San Francisco, California and Fort Worth, Texas for a combined purchase price of approximately $20.6 million. These locations serve a population of about 3.3 million people and are part of Roto-Rooter's ongoing strategy to acquire franchises and boost productivity, market share, and profitability.

CHE acquisition Roto-Rooter franchise San Francisco Fort Worth expansion market share
Sentiment note

The company is actively executing its growth strategy through strategic acquisitions in significant territories, expanding its market presence and customer base. The acquisition of two major metropolitan areas (San Francisco and Fort Worth) demonstrates confidence in business expansion and should contribute to increased profitability and market share.

Negative GlobeNewswire Inc. • Johnson Fistel, Pllp
Chemed Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Johnson Fistel, PLLP is investigating potential securities law violations by Chemed Corporation following the company's February 26, 2026 earnings report that missed consensus estimates by $0.61 per share and $19.8 million in revenue, resulting in a stock price decline. The law firm is seeking investors who suffered losses to join the investigation.

CHE securities fraud earnings miss investor losses class action investigation federal securities laws financial results
Sentiment note

Chemed reported fourth quarter 2025 results that significantly missed analyst expectations (EPS miss of $0.61 and revenue miss of $19.8 million), leading to a stock price decline and triggering a securities investigation into potential compliance violations with federal securities laws.

Neutral The Motley Fool • Jonathan Ponciano
Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake

Barington Companies Management established a new position in Chemed Corporation by acquiring 13,000 shares valued at $5.56 million, representing 3.65% of its reportable assets. Despite Chemed's stock declining 15.18% over the past year, the investment signals conviction in the company's strong balance sheet, cash generation, and defensive business model spanning hospice care (VITAS) and plumbing services (Roto-Rooter), despite recent margin pressures.

CHE Chemed Corporation Barington Companies Management hospice care Roto-Rooter stock decline institutional investment balance sheet strength
Sentiment note

While the stock has declined 15% year-over-year and faced recent margin pressures and EPS declines, the company maintains strong fundamentals including $129.8 million in cash, no debt, consistent revenue growth (3.1% YoY), and positive demographic tailwinds in hospice care. The institutional investment by Barington suggests confidence in long-term value despite short-term sentiment weakness.

Positive Benzinga • Globe Newswire
Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents

Chemed Corporation announced a $300 million authorization for stock repurchases and declared a quarterly dividend of $0.60 per share, payable on March 13, 2026. This marks the 219th consecutive quarterly dividend in the company's 54 years as a public company. The repurchases will be funded through operational cash flow and its revolving credit facility.

CHE stock repurchase dividend shareholder returns capital allocation hospice care plumbing services
Sentiment note

The company is demonstrating strong financial health and confidence in its business by authorizing a substantial $300 million share repurchase program and maintaining consistent dividend payments (219 consecutive quarters). These actions indicate robust cash generation and shareholder-friendly capital allocation, which are typically viewed positively by investors.

Positive Benzinga • Globe Newswire
Chemed Corporation Declares Quarterly Dividend of 60 Cents

Chemed Corporation announced a quarterly cash dividend of 60 cents per share, payable on December 5, 2025, to shareholders of record as of November 17, 2025. This marks the 218th consecutive quarterly dividend in the company's 54-year history.

CHE dividend quarterly dividend hospice care plumbing services
Sentiment note

Consistent dividend payment demonstrates financial stability and commitment to shareholders, with this being their 218th consecutive quarterly dividend

Neutral GlobeNewswire Inc. • Michael D. Witzeman
Chemed Corporation to Present at the UBS 2025 Global Healthcare Conference

Chemed Corporation will present at the UBS 2025 Global Healthcare Conference, discussing its performance across its two subsidiaries: VITAS Healthcare and Roto-Rooter.

CHE healthcare conference earnings hospice care plumbing services
Sentiment note

The article presents standard corporate communication about an upcoming conference presentation without indicating significant positive or negative performance indicators

Negative The Motley Fool • Cory Renauer
Schwartz Offloads 28,000 Chemed (CHE) Shares Valued at $13 Million

Schwartz Investment Counsel sold 28,771 shares of Chemed Corporation, reducing its stake to 111,033 shares, representing 1.67% of its reportable assets. The sale was driven by disappointing quarterly results and declining performance in both hospice care and plumbing segments.

CHE MA NVDA Chemed stock sale hospice care plumbing services investment
Sentiment note

Stock is down 33.7% from its peak, reported disappointing Q3 results with declining EBITDA in both hospice care and Roto-Rooter segments, and underperformed the S&P 500 by 45.55 percentage points over the past year

Unknown Seeking Alpha • Justin Law
Dividend Champion, Contender, And Challenger Highlights: Week Of May 26

Stay up-to-date on dividend activity, changes, ex-dividend dates, and pay dates for Dividend Champions, Contenders, and Challengers in our weekly summary.

EQH FLO HLNE LII
Unknown Zacks Investment Research • Zacks Equity Research
Chemed (CHE) Down 3.1% Since Last Earnings Report: Can It Rebound?

Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CHE
Unknown Zacks Investment Research • Zacks Equity Research
Should iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV) Be on Your Investing Radar?

Style Box ETF report for SMMV

SMMV MUSA CHE IWM
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal